Which medications in the drug class Somatostatin Analogs are used in the treatment of Insulinoma?

Updated: May 31, 2020
  • Author: Zonera Ashraf Ali, MBBS; Chief Editor: Neetu Radhakrishnan, MD  more...
  • Print

Somatostatin Analogs

May control symptoms by suppressing secretion of gastroenteropancreatic peptides including insulin. High-dose treatment also may lead to additional antiproliferative effects. However, long-term application of somatostatin may down-regulate receptor expression levels, resulting in decreased efficiency despite increasing doses. Both short- and long-acting depot preparations are available.

Lanreotide (Somatuline Depot)

Long-acting analog of somatostatin, administered q4wk.

Octreotide acetate (Sandostatin)

Acts similarly to the natural hormone somatostatin and can suppress secretion of gastroenteropancreatic peptides, including insulin.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!